Exploring the mechanism of LncRNA CASC15 affecting hepatocellular carcinoma through miRNA

Qingshan Cai,Dongyang Wu,Yueling Shen,Shudong Li,Liyou Liu,Dong Liu,Yong Li,Xiaonan Chen,Limin Wang,Jianxing Zheng

DOI: https://doi.org/10.1097/md.0000000000035859

IF: 1.6

2024-02-03

Medicine

Abstract:Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and the fourth leading cause of cancer-related death. [ 1 ] With an estimated 906,000 new diagnoses and 830,000 (8.3%) deaths in 2020, HCC has become a major threat to human health. [ 2 ] Surgical resection, ablation, liver transplantation, and embolization have been clinically applied to treat HCC. [ 3 ] However, due to a complex etiology, hidden onset, aggressive malignancy, and rapid progression, HCC is usually diagnosed only after it has reached an advanced stage. [ 4 ] The absence of effective post-treatment regulatory mechanisms for HCC has resulted in 2- and 5-year recurrence rates of up to 50% and 75%, respectively. [ 5 ] The 5-year survival rate of HCC patients is only 18%. [ 6 ] Hence, the underlying molecular mechanisms of HCC occurrence and development must be clarified as soon as possible to improve prognosis monitoring and treatment and reduce mortality rates.

medicine, general & internal